LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Dworschak-Simpson, Sierra"
  2. AU="Jurisica, Igor"
  3. AU="Ye, Jessica Meng"
  4. AU="Kiyoshi Takahara"
  5. AU="Sofía Bauer"
  6. AU="Randriamboavonjy, Joseph Iharinjaka"
  7. AU="DiFazio, Louis T"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: A designed inhibitor of a CLC antiporter blocks function through a unique binding mode.

Howery, Andrew E / Elvington, Shelley / Abraham, Sherwin J / Choi, Kee-Hyun / Dworschak-Simpson, Sierra / Phillips, Sabrina / Ryan, Christopher M / Sanford, R Lea / Almqvist, Jonas / Tran, Kevin / Chew, Thomas A / Zachariae, Ulrich / Andersen, Olaf S / Whitelegge, Julian / Matulef, Kimberly / Du Bois, Justin / Maduke, Merritt C

Chemistry & biology

2012  Band 19, Heft 11, Seite(n) 1460–1470

Abstract: The lack of small-molecule inhibitors for anion-selective transporters and channels has impeded our understanding of the complex mechanisms that underlie ion passage. The ubiquitous CLC "Chloride Channel" family represents a unique target for biophysical ...

Abstract The lack of small-molecule inhibitors for anion-selective transporters and channels has impeded our understanding of the complex mechanisms that underlie ion passage. The ubiquitous CLC "Chloride Channel" family represents a unique target for biophysical and biochemical studies because its distinctive protein fold supports both passive chloride channels and secondary-active chloride-proton transporters. Here, we describe the synthesis and characterization of a specific small-molecule inhibitor directed against a CLC antiporter (ClC-ec1). This compound, 4,4'-octanamidostilbene-2,2'-disulfonate (OADS), inhibits ClC-ec1 with low micromolar affinity and has no specific effect on a CLC channel (ClC-1). Inhibition of ClC-ec1 occurs by binding to two distinct intracellular sites. The location of these sites and the lipid dependence of inhibition suggest potential mechanisms of action. This compound will empower research to elucidate differences between antiporter and channel mechanisms and to develop treatments for CLC-mediated disorders.
Mesh-Begriff(e) Antiporters/antagonists & inhibitors ; Antiporters/chemistry ; Antiporters/genetics ; Antiporters/metabolism ; Binding Sites ; Chloride Channels/metabolism ; Escherichia coli Proteins/antagonists & inhibitors ; Escherichia coli Proteins/chemistry ; Escherichia coli Proteins/genetics ; Escherichia coli Proteins/metabolism ; Lipid Bilayers ; Molecular Dynamics Simulation ; Mutation ; Stilbenes/metabolism ; Stilbenes/pharmacology ; Sulfonic Acids/metabolism ; Sulfonic Acids/pharmacology
Chemische Substanzen 4,4'-octanamidostilbene-2,2'-disulfonic acid ; Antiporters ; CLC-1 channel ; CLC-ec1 protein, E coli ; Chloride Channels ; Escherichia coli Proteins ; Lipid Bilayers ; Stilbenes ; Sulfonic Acids
Sprache Englisch
Erscheinungsdatum 2012-11-21
Erscheinungsland United States
Dokumenttyp Journal Article ; Research Support, American Recovery and Reinvestment Act ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID 917827-2
ISSN 1879-1301 ; 1074-5521
ISSN (online) 1879-1301
ISSN 1074-5521
DOI 10.1016/j.chembiol.2012.09.017
Signatur
Zs.A 4429: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang